Emany Sravan Kumar
SEC CIK 1897662 · EDGAR
BoughtSold
Most active insiders at BEAM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FMR LLC | 10%, See Remark 1 | — | $10.05M |
| 2 | Evans John M. | CEO, Dir | — | $6.28M |
| 3 | Ciaramella Giuseppe | Pres | — | $1.41M |
| 4 | Bellon Christine | CLO | — | $881.0K |
| 5 | Simon Amy | Chief Medical Off | — | $606.7K |
| 6 | Cavanagh Bethany J | SVP, Fin, Treas | — | $399.5K |
| 7 | Emany Sravan Kumar | CFO | — | $170.6K |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 17:16 | 2026-03-31 | BEAM | Beam Therapeutics Inc. | Emany Sravan Kumar | CFO | A - Grant | $0.00 | +31.8K | 105.5K | +43% | $0 | |
| D | 2026-02-26 | 2026-02-24 | KYTX | Kyverna Therapeutics, Inc. | Emany Sravan Kumar | Dir | A - Grant | $0.00 | +11.0K | 11.0K | New | $0 |
| T | 2026-01-05 | 2025-12-31 | BEAM | Beam Therapeutics Inc. | Emany Sravan Kumar | CFO | S - Sale | $27.10 | -6,294 | 73.7K | -8% | -$170.6K |
| D | 2025-01-02 | 2024-12-31 | BEAM | Beam Therapeutics Inc. | Emany Sravan Kumar | CFO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
| 2024-11-20 | 2024-11-18 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, COO, CFO | S - Sale | $4.08 | -11.0K | 309.6K | -3% | -$44.9K | |
| 2024-05-20 | 2024-05-16 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | F - Tax | $6.64 | -18.3K | 320.6K | -5% | -$121.4K | |
| D | 2024-03-12 | 2024-03-08 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | M - OptEx | $0.00 | +37.1K | 338.9K | +12% | $0 |
| 2024-03-06 | 2024-03-04 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | P - Purchase | $9.38 | +10.7K | 301.7K | +4% | +$100.2K | |
| D | 2024-02-14 | 2024-02-12 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +65.3K | 291.0K | +29% | $0 |
| 2024-02-12 | 2024-02-08 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | F - Tax | $14.90 | -41.3K | 225.7K | -15% | -$615.8K | |
| 2024-01-19 | 2024-01-17 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +85.0K | 267.1K | +47% | $0 | |
| 2023-11-20 | 2023-11-16 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | F - Tax | $9.44 | -6,661 | 182.1K | -4% | -$62.9K | |
| 2023-09-18 | 2023-09-15 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | P - Purchase | $8.32 | +36.1K | 188.7K | +24% | +$300.1K | |
| D | 2023-03-10 | 2023-03-08 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +74.2K | 152.7K | +95% | $0 |
| 2022-11-23 | 2022-11-21 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | S - Sale | $11.56 | -6,578 | 78.4K | -8% | -$76.0K | |
| 2021-12-08 | 2021-12-06 | IRWD | IRONWOOD PHARMACEUTICALS INC | Emany Sravan Kumar | SVP, CFO | A - Grant | $0.00 | +85.0K | 85.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations